Blogs
Explainer
A plain-language guide to the biology behind Neoantigen Retriever and the steps between a tumour mutation and a personalized vaccine.
October 9, 2026 · 5 min read
Development roadmap
Why a working computational pipeline is a starting point, and how biological evidence changes the next version.
Platform vision
How a coordinated network can make personalized vaccine development more repeatable, with Neoantigen Retriever at the computational handoff.
October 9, 2026 · 4 min read
Company mission
The accessibility question behind N1 Therapeutics, and why clinical collaboration comes first.
